AP-103

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAP-103
Drug Alias NameAP-103
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCollagen stimulantsGene transference
TargetsCollagen
Therapy Area/IndicationsEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity College Dublin
China Registration ClassN/A

Develop Information

Active CompaniesAmryt Pharma
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A